Business
Beckman Coulter Lauded by Frost & Sullivan for Accelerating Sepsis Detection with the DxH 690T
Beckman Coulter Lauded by Frost & Sullivan for Accelerating Sepsis Detection with the ...
About this update from Discovery Harbour Resources Corp.
[{"type":"text","content":"\n\n\n\nBeckman Coulter Lauded by Frost & Sullivan for Accelerating Sepsis Detection with the DxH 690T\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nBeckman Coulter Lauded by Frost & Sullivan for Accelerating Sepsis Detection with the DxH 690T\nCanada NewsWire\nSANTA CLARA, Calif., Sept. 15, 2020\n\n\n\nThe technology is superior at identifying cell types in human blood, providing faster and more reliable assessments for clinical decision making\n SANTA CLARA, Calif., Sept. 15, 2020 /CNW/ -- Based on its recent analysis of the global hematology testing market, Frost & Sullivan recognizes Beckman Coulter Diagnostics with the 2020 Global New Product Innovation Award for the DxH 690T. The company developed the tabletop hematology analyzer for mid-volume laboratories, community hospitals and physician offices, without compromising clinical effectiveness. With 93% first-pass yield and 75% fewer quality control steps compared to other commercially-available systems, the DxH 690T provides laboratories a more streamlined workflow with increased uptime and lower overhead costs.\n\n \n \n \n \n \n \n\n \n\"The DxH 690T leverages flagship products in the Beckman Coulter Diagnostics' portfolio, specifically the enhanced Coulter Principle, VCS technology and DataFusion, to provide precise cellular assessments of RBCs, WBCs and platelets. The DxH 690T is more effective and efficient than competing devices at detecting the variety of cell types and morphologies, particularly with abnormalities,\" said Norma Vela Industry Analyst, Frost & Sullivan. \"The DxH 690T reduces the need for manual interventions and specimen re-dos, thus streamlining laboratory workflows and increasing productivity.\"\nThe DxH 690T's automated capabilites are a significant benefit because of worker shortages and financial pressures in healthcare. Beckman Coulter designed the DxH 690T with medium-sized hospitals and mid-volume laboratories in mind to increase walkaway times, minimize touchpoints and maximize uptime. \nSignificantly, the DxH 690T also supports early detection of sepsis for ...